IL17A and rheumatoid arthritis: In animal models, RA is able to inhibit IL-17A secretion, IL-6R, IL-23R expression, regulate MMPs/TIMPs and TGF-β1 expression, and thus regulate the development of inflammation and fibrosis (Figure 3).